Brain-derived neurotrophic factor gene-modified bone marrow mesenchymal stem cells.

Area of Science:

• Stem Cell Biology
• Neuroscience
• Gene Therapy

Background:

• Mesenchymal stem cells (MSCs) are multipotent cells with potential for neural differentiation.
• Human brain-derived neurotrophic factor (hBDNF) is crucial for neuronal survival and growth.
• Investigating hBDNF's role in MSC neural differentiation is key for regenerative medicine.

Purpose of the Study:

• To investigate the effect of hBDNF gene transfection on the differentiation of rat bone marrow stromal cells (BMSCs) into neuron-like cells.
• To assess the efficacy of lentiviral vectors for delivering the hBDNF gene into BMSCs.
• To quantify the enhancement in neural differentiation rates post-transfection.

Main Methods:

• Isolation, culture, and identification of Sprague-Dawley rat BMSCs.
• Transfection of BMSCs using lentiviral vectors carrying hBDNF and eGFP genes.
• Assessment of cell proliferation (MTT assay), transfection efficiency (eGFP expression), and hBDNF expression (RT-qPCR, Western blot).
• In vitro induction of neuron-like cell differentiation and statistical comparison of differentiation rates.

Main Results:

• Flow cytometry confirmed BMSCs expressed CD90 and CD44, and lacked CD34 and CD45.
• Gene transfection increased BMSC proliferation and successfully expressed hBDNF-eGFP.
• hBDNF-modified BMSCs showed significantly higher differentiation rates into neuron-like cells compared to controls (P<0.05).

Conclusions:

• Lentiviral-mediated hBDNF gene transfection effectively promotes the differentiation of BMSCs into neuron-like cells.
• hBDNF plays a significant role in guiding MSC differentiation towards a neural lineage.
• This approach holds promise for neural regenerative therapies.